KPRXKIORA PHARMACEUTICALS INC同业对比
KIORA PHARMACEUTICALS INC 与SIC 2834 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KPRX本股 | $7M#8 | — | 0.4x#5 | — | -100.0%#6 | -401.4%#16 | — | -0.1%#2 | -127.6%#3 | — | — | — |
| MTVA | $9M#1 | — | 1.3x#10 | — | — | 53.0%#2 | — | -190.2%#9 | — | — | -88.3%#5 | — |
| ACTU | $9M#2 | — | 9.0x#13 | — | — | 18.5%#6 | — | -2247.2%#13 | — | — | — | — |
| TOVX | $8M#4 | 0.1x#1 | 0.1x#1 | — | -100.0%#6 | 7.5%#8 | — | -42.1%#6 | -51.4%#1 | — | — | — |
| SNGX | $8M#5 | — | 1.2x#8 | 65.6x#5 | -85.8%#5 | -33.7%#12 | -9923.2%#5 | -167.0%#8 | — | 5#1 | — | — |
| VTGN | $8M#3 | — | 0.3x#3 | 6.5x#3 | 161.1%#1 | -35.5%#13 | -5683.7%#3 | -284.7%#10 | -949.7%#4 | — | — | — |
| LTRN | $8M#6 | — | — | — | — | 17.6%#7 | — | — | — | — | — | — |
| ALZN | $7M#7 | — | 1.3x#9 | — | — | -94.3%#15 | — | -151.2%#7 | — | — | -38.6%#1 | — |
| APRE | $7M#9 | — | 0.2x#2 | — | — | 2.8%#9 | — | -36.9%#5 | — | — | — | — |
| ENSC | $7M#10 | — | — | 1.4x#2 | -2.8%#2 | -27.4%#11 | -202.1%#2 | — | — | — | -82.9%#4 | — |
| SYBX | $7M#11 | — | 0.6x#6 | — | -100.0%#6 | 95.7%#1 | — | -8.4%#4 | — | — | -66.1%#2 | — |
| TPST | $7M#12 | — | — | 23.3x#4 | -54.8%#4 | 37.2%#4 | -9008.5%#4 | — | — | — | — | — |
| FBLG | $7M#13 | 0.3x#2 | 1.4x#11 | — | — | -67.1%#14 | — | -402.2%#11 | -1409.7%#5 | — | — | — |
| ENVB | $6M#15 | — | 0.8x#7 | 0.2x#1 | -7.2%#3 | 26.0%#5 | -22.0%#1 | 149.7%#1 | -100.4%#2 | 3#2 | -77.1%#3 | — |
| CNSP | $6M#16 | — | 0.4x#4 | — | — | -7.6%#10 | — | -0.1%#3 | — | — | — | — |
| XCUR | $6M#14 | — | 6.6x#12 | — | -100.0%#6 | 49.0%#3 | — | -506.2%#12 | — | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-11-04。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议